array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Tekla Life Sciences Investors" ["slug"]=> string(38) "30be8-us-tekla-life-sciences-investors" ["logo"]=> NULL ["description"]=> string(523) "Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL." ["address_street"]=> string(17) "2 Liberty Sq FL 9" ["address_place"]=> string(6) "Boston" ["address_region"]=> string(13) "Massachusetts" ["founding_date"]=> string(10) "2000-01-26" ["website_domain"]=> string(12) "teklacap.com" ["website_url"]=> string(24) "https://www.teklacap.com" ["industry_codes"]=> array(1) { [0]=> string(39) "Management Investment Offices, Open-End" } ["employee_count"]=> int(7) ["article_count"]=> int(78) } ["articles"]=> array(5) { [0]=> array(7) { ["title_en"]=> string(82) "Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)" ["snippet_en"]=> string(300) "Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s" ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-09-29/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/28564341-88d3-4b88-b2ed-9009ed96617e" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2023-09-29" ["categories"]=> array(10) { [0]=> string(19) "Investment Requests" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(11) "Acquisition" [3]=> string(24) "Stock Research & Ratings" [4]=> string(11) "Regulations" [5]=> string(31) "Financial Update/Profit Warning" [6]=> string(14) "Issuing Shares" [7]=> string(16) "Share Repurchase" [8]=> string(12) "Stock Market" [9]=> string(18) "General Investment" } } [1]=> array(7) { ["title_en"]=> string(35) "Tekla Life Sciences Investors (HQL)" ["snippet_en"]=> string(102) "This page features all of the latest analysis and reports for the Tekla Life Sciences Investors stock." ["url"]=> string(71) "https://au.investing.com/equities/tekla-life-sciences-investors-opinion" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> string(10) "2022-08-16" ["categories"]=> array(2) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" } } [2]=> array(7) { ["title_en"]=> string(35) "Tekla Life Sciences Investors (HQL)" ["snippet_en"]=> string(106) "Get details on the Tekla Life Sciences Investors stock dividend history and find the HQL ex-dividend date." ["url"]=> string(74) "https://www.investing.com/equities/tekla-life-sciences-investors-dividends" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> NULL ["categories"]=> array(2) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" } } [3]=> array(7) { ["title_en"]=> string(35) "Tekla Life Sciences Investors (HQL)" ["snippet_en"]=> string(191) "Get today's Tekla Life Sciences Investors stock news. We cover the latest Tekla Life Sciences Investors headlines and breaking news impacting Tekla Life Sciences Investors stock performance." ["url"]=> string(69) "https://www.investing.com/equities/tekla-life-sciences-investors-news" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> NULL ["categories"]=> array(2) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" } } [4]=> array(7) { ["title_en"]=> string(35) "Tekla Life Sciences Investors (HQL)" ["snippet_en"]=> string(102) "This page contains all of the latest analysis and reports for the Tekla Life Sciences Investors stock." ["url"]=> string(72) "https://www.investing.com/equities/tekla-life-sciences-investors-opinion" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> NULL ["categories"]=> array(2) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" } } } ["category_annotations"]=> array(22) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(16) } [1]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(6) } [2]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(6) } [3]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(5) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(4) } [5]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(4) } [6]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(4) } [7]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(4) } [8]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [9]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [13]=> array(2) { ["name"]=> string(22) "Business Restructuring" ["count"]=> int(2) } [14]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(2) } [15]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(23) "Supply Chain Management" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(19) "Investment Requests" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(1) } } } 30be8-us-tekla-life-sciences-investors